Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

In utero gene editing for monogenic lung disease.

Alapati D, Zacharias WJ, Hartman HA, Rossidis AC, Stratigis JD, Ahn NJ, Coons B, Zhou S, Li H, Singh K, Katzen J, Tomer Y, Chadwick AC, Musunuru K, Beers MF, Morrisey EE, Peranteau WH.

Sci Transl Med. 2019 Apr 17;11(488). pii: eaav8375. doi: 10.1126/scitranslmed.aav8375.

PMID:
30996081
2.

Beyond scattering and absorption: Perceptual unmixing of translucent liquids.

Chadwick AC, Cox G, Smithson HE, Kentridge RW.

J Vis. 2018 Oct 1;18(11):18. doi: 10.1167/18.11.18.

3.

In utero CRISPR-mediated therapeutic editing of metabolic genes.

Rossidis AC, Stratigis JD, Chadwick AC, Hartman HA, Ahn NJ, Li H, Singh K, Coons BE, Li L, Lv W, Zoltick PW, Alapati D, Zacharias W, Jain R, Morrisey EE, Musunuru K, Peranteau WH.

Nat Med. 2018 Oct;24(10):1513-1518. doi: 10.1038/s41591-018-0184-6. Epub 2018 Oct 8.

4.

Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3.

Chadwick AC, Evitt NH, Lv W, Musunuru K.

Circulation. 2018 Feb 27;137(9):975-977. doi: 10.1161/CIRCULATIONAHA.117.031335. No abstract available.

5.

Translucence perception is not dependent on cortical areas critical for processing colour or texture.

Chadwick AC, Heywood CA, Smithson HE, Kentridge RW.

Neuropsychologia. 2019 May;128:209-214. doi: 10.1016/j.neuropsychologia.2017.11.009. Epub 2017 Nov 15.

6.

CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.

Chadwick AC, Musunuru K.

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):12-18. doi: 10.1161/ATVBAHA.117.309326. Epub 2017 Aug 24. Review.

7.

In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.

Chadwick AC, Wang X, Musunuru K.

Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1741-1747. doi: 10.1161/ATVBAHA.117.309881. Epub 2017 Jul 27.

8.

Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing.

Chadwick AC, Musunuru K.

Curr Atheroscler Rep. 2017 Jul;19(7):32. doi: 10.1007/s11883-017-0668-8. Review.

9.

Genome Editing for the Study of Cardiovascular Diseases.

Chadwick AC, Musunuru K.

Curr Cardiol Rep. 2017 Mar;19(3):22. doi: 10.1007/s11886-017-0830-5. Review.

10.

NMR Structure of the C-Terminal Transmembrane Domain of the HDL Receptor, SR-BI, and a Functionally Relevant Leucine Zipper Motif.

Chadwick AC, Jensen DR, Hanson PJ, Lange PT, Proudfoot SC, Peterson FC, Volkman BF, Sahoo D.

Structure. 2017 Mar 7;25(3):446-457. doi: 10.1016/j.str.2017.01.001. Epub 2017 Feb 2.

11.

Oxidized LDL-bound CD36 recruits an Na⁺/K⁺-ATPase-Lyn complex in macrophages that promotes atherosclerosis.

Chen Y, Kennedy DJ, Ramakrishnan DP, Yang M, Huang W, Li Z, Xie Z, Chadwick AC, Sahoo D, Silverstein RL.

Sci Signal. 2015 Sep 8;8(393):ra91. doi: 10.1126/scisignal.aaa9623. Erratum in: Sci Signal. 2015 Oct 6;8(397):er7.

12.

Impairment of Macrophage Cholesterol Efflux by Cholesterol Hydroperoxide Trafficking: Implications for Atherogenesis Under Oxidative Stress.

Korytowski W, Wawak K, Pabisz P, Schmitt JC, Chadwick AC, Sahoo D, Girotti AW.

Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2104-13. doi: 10.1161/ATVBAHA.115.306210. Epub 2015 Aug 27.

13.

Acrolein impairs the cholesterol transport functions of high density lipoproteins.

Chadwick AC, Holme RL, Chen Y, Thomas MJ, Sorci-Thomas MG, Silverstein RL, Pritchard KA Jr, Sahoo D.

PLoS One. 2015 Apr 7;10(4):e0123138. doi: 10.1371/journal.pone.0123138. eCollection 2015.

14.

Inhibition of an NAD⁺ salvage pathway provides efficient and selective toxicity to human pluripotent stem cells.

Kropp EM, Oleson BJ, Broniowska KA, Bhattacharya S, Chadwick AC, Diers AR, Hu Q, Sahoo D, Hogg N, Boheler KR, Corbett JA, Gundry RL.

Stem Cells Transl Med. 2015 May;4(5):483-93. doi: 10.5966/sctm.2014-0163. Epub 2015 Apr 1.

15.

Expression, purification and reconstitution of the C-terminal transmembrane domain of scavenger receptor BI into detergent micelles for NMR analysis.

Chadwick AC, Jensen DR, Peterson FC, Volkman BF, Sahoo D.

Protein Expr Purif. 2015 Mar;107:35-42. doi: 10.1016/j.pep.2014.11.001. Epub 2014 Nov 12.

16.

The perception of gloss: a review.

Chadwick AC, Kentridge RW.

Vision Res. 2015 Apr;109:221-35. doi: 10.1016/j.visres.2014.10.026. Epub 2014 Nov 8. Review.

17.

Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: an old dog with new tricks.

Chadwick AC, Sahoo D.

Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):124-31. doi: 10.1097/MED.0b013e32835ed575. Review.

18.

Functional characterization of newly-discovered mutations in human SR-BI.

Chadwick AC, Sahoo D.

PLoS One. 2012;7(9):e45660. doi: 10.1371/journal.pone.0045660. Epub 2012 Sep 21.

19.

CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.

Beres AJ, Haribhai D, Chadwick AC, Gonyo PJ, Williams CB, Drobyski WR.

J Immunol. 2012 Jul 1;189(1):464-74. doi: 10.4049/jimmunol.1200886. Epub 2012 May 30.

20.

Proceedings: Effect of methallibure on prolactin release from pigeon pituitaries incubated in vitro.

Hall TR, Chadwick AC.

J Endocrinol. 1975 Mar;64(3):72P. No abstract available.

PMID:
1133563
21.

Proceedings: Thyrotropin releasing factor and prolactin release in the pigeon in vivo.

Chadwick AC, Hall TR.

J Endocrinol. 1975 Mar;64(3):26P-27P. No abstract available.

PMID:
805819

Supplemental Content

Loading ...
Support Center